Optical coherence tomography findings after drug-coated balloon treatment for de novo coronary artery lesions with eruptive calcified nodule
Frontiers in Cardiovascular Medicine · 13.11.2025 · 12
DOI: 10.3389/fcvm.2025.1666458 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 13.11.2025. Verfasst von Kazuki Matsuda und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The purpose of the present study was to investigate the factors associated with worse clinical outcomes in patients with de novo eruptive calcified nodule (CN) lesions after stent-less percutaneous coronary intervention (PCI) with a drug-coated balloon (DCB), as assessed by optical coherence tomography (OCT) and morphological findings at target lesion revascularization (TLR) or during the follow-up period. We retrospectively enrolled 68 de novo eruptive coronary artery eruptive CN lesions in 58 patients who underwent PCI with DCB. All lesions were treated without stents and underwent both pre- and post-PCI OCT. The patients were divided into two groups: those with or without target lesion failure (TLF), defined as a composite of culprit lesion-related cardiac death, myocardial infarction, and TLR. At a median follow-up period of 650 days, TLF events occurred in 14 lesions (20.6%) and were associated with the absence of medial involvement of coronary artery dissection on post-PCI OCT (28.6% vs. 70.4%, P = 0.006). In the subgroup analysis of 16 lesions with serial OCT imaging (pre-and post-PCI at the index PCI and at TLR or follow-up), TLR occurred in nine lesions. We found CN protrusion at TLR in seven lesions, layered plaque at TLR in one lesion, and suboptimal lumen expansion at the index PCI in another lesion as restenosis patterns. Moreover, CN protrusion was significantly more frequent in TLR lesions than in the seven non-TLR lesions (77.8% vs. 14.3%, P = 0.041). In conclusion, we observed a high incidence of TLF after DCB treatment for de novo eruptive CN coronary artery lesions, which correlated with the absence of medial involvement in dissection. CN protrusion is frequently observed in TLR lesions, whereas late lumen enlargement is predominantly observed in non-TLR lesions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.
- Department of Cardiovascular Medicine, Institute of Science Tokyo, Tokyo, Japan.
Zitieren
APA
Matsuda, K., Lee, T., Ashikaga, T., Nozato, T., Nagata, Y., Kaneko, M., Miyazaki, R., Misawa, T., Nagase, M., Horie, T., Terui, M., Kachi, D., Odanaka, Y., Ohira, M., Kikkoji, N., Koido, A., Kou, M., Baba, R., Takakuma, A., …, & Sasano, T. (2025). Optical coherence tomography findings after drug-coated balloon treatment for de novo coronary artery lesions with eruptive calcified nodule. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1666458
Vancouver
Matsuda K, Lee T, Ashikaga T, Nozato T, Nagata Y, Kaneko M, et al. Optical coherence tomography findings after drug-coated balloon treatment for de novo coronary artery lesions with eruptive calcified nodule. Frontiers in Cardiovascular Medicine. 2025;12. doi:10.3389/fcvm.2025.1666458
BibTeX
@article{Matsuda2025,
author = {Matsuda, Kazuki and Lee, Tetsumin and Ashikaga, Takashi and Nozato, Toshihiro and Nagata, Yasutoshi and Kaneko, Masakazu and Miyazaki, Ryoichi and Misawa, Toru and Nagase, Masashi and Horie, Tomoki and Terui, Mao and Kachi, Daigo and Odanaka, Yuki and Ohira, Maki and Kikkoji, Naoya and Koido, Ayaka and Kou, Megumi and Baba, Risako and Takakuma, Akira and Yonetsu, Taishi and Sasano, Tetsuo},
title = {Optical coherence tomography findings after drug-coated balloon treatment for de novo coronary artery lesions with eruptive calcified nodule},
journal = {Frontiers in Cardiovascular Medicine},
year = {2025},
volume = {12},
doi = {10.3389/fcvm.2025.1666458}
}
EUVIMED